News
Amgen (AMGN) stock in focus as its antibody drug Tepezza becomes U.K.'s first medicine for adults with moderate to severe ...
As with all products, the MHRA will keep its safety under close review. The Medicines and Healthcare products Regulatory ...
5d
Pharmaceutical Technology on MSNMHRA authorises Bavarian Nordic’s chikungunya virus vaccineThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...
The Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Vimkunya, a vaccine used to prevent disease caused by the chikungunya virus in people 12 years of age and older. The ...
VIMKUNYA is a single dose, prefilled, adjuvanted VLP recombinant protein vaccine for active immunization for the prevention ...
In dawn raids in four counties across the West Midlands and Northwest of England this morning, 12 suspects were arrested in what is the largest criminal investigation into organised medicines ...
1d
Pharmaceutical Technology on MSNExpediting parallel drug approval pathways is challenging, but rewardingGlobal agencies have collaborated to create parallel regulatory approval solutions to help get drugs to patients more quickly ...
A borough individual is one of 12 who have been arrested on suspicion of trafficking medicine.
Sangamo Therapeutics, Inc. , a genomic medicine company, today announced important derisking events in the pathway to a planned BLA submission for isaralgagene civaparvovec, or ST-920, its wholly ...
This follows the UK Medicines and Healthcare Products Regulatory Agency’s 2022 update, which removed the default requirement for these trials where clear scientific rationale exists. There’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results